Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.
Also called NCT00994617
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Registry
-
NCT00994617
-
- Other papers using this trial's data
- Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT00994617. Randomized; double masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
- Acronym
- Pathway 1
- Condition
- Hypertension, Resistant to Conventional Therapy
- Condition
- Essential Hypertension
- Intervention (Drug)
- Losartan and hydrochlorothiazide
- Intervention (Drug)
- Hydrochlorothiazide switched over with Losartan at 8 weeks
- Lead sponsor
- University of Cambridge
- Collaborator
- British Heart Foundation
Record details
- Record id
cardio:ct-nct00994617- Content hash
b6082b86dc02361e81007a08e0f55463524318fa2037490ba6877b3aaa6e37c9